NEOGENIX ONCOLOGY

Swiss trademark · 603086 · Word mark · Deleted

Register entry

Registration number
603086
Application number
51077/2010
Status
Deleted
Type
Word mark
Filed
Feb 3, 2010
Registered
Jul 20, 2010
Published
Jul 20, 2010
Deleted
Aug 26, 2020
Reason
Not renewed
Priority
03.08.2009 US
Source
Swissreg

Goods and services

Pharmaceuticals

Diagnostische und therapeutische monoklonale Antikörper und Impfstoffe, für die Diagnose und Behandlung von Krebs und die Immunisierung gegen Krebs.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 26, 2020

    Deleted, not renewed

    Published in Swissreg on 26.08.2020

  2. Sep 13, 2017

    Agent’s address changed

    Representative
    Rentsch Partner AG, Fraumünsterstrasse 9, Postfach 2441, 8022 Zürich → RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 13.09.2017

  3. Jun 20, 2011

    Agent’s address changed

    Representative
    Rentsch & Partner, Fraumünsterstrasse 9,, Postfach 2441, 8022 Zürich → Rentsch Partner AG, Fraumünsterstrasse 9, Postfach 2441, 8022 Zürich

    Published in Swissreg on 20.06.2011

  4. Jul 20, 2010

    Registered

    Published in Swissreg on 20.07.2010

Parties

Holder

Neogenix Oncology, Inc.

445 Northern Boulevard Suite 24 Great Neck, 11021 New York, US

Agent

RENTSCH PARTNER AG

Bellerivestrasse 203 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.